NewScen Coast Bio Pharmaceutical Co. Ltd. is a joint venture company headquartered in Tianjin City, China, that manufactures and distributes in-vitro diagnostic devices.

Beijing Marr Bio-Pharmaceutical Co. Ltd., a subsidiary of Humanwell Healthcare (Group) Co., Ltd., is a Chinese company located in Beijing. The firm produces venereal disease test kits. David K. Harris is the current CEO of the firm. On May 30, 2011 Humanwell Healthcare (Group) Co., Ltd. acquired Beijing Marr Bio-Pharmaceutical Co. Ltd. from Calypte Biomedical Corp. for $1.08 million.

SRD Pharmaceuticals, Inc. is a private company headquartered in Westport, CT, that manufactures pharmaceutical drugs.

Kemei Boyang Diagnostic Technology (Shanghai) Co., Ltd., established on 2005-08-17, Business scope includes general items:Diagnostic Technology,medical technology,Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technical services in the field,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biological product,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Own Equipment Rental;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Beijing Liangxin Biotechnology Development Co., Ltd., established on 2019-09-23, Business scope includes technical promotion services;software development;Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nissin Foods Holdings Co., Ltd. engages in the management of its group companies which are in the food manufacturing business. It operates through the following segments: Nissin Food Products, Myojo Foods, Chilled and Frozen Foods, The Americas, China, and Others. The Nissin Food Products, Myojo Foods, The Americas, and China segments produces and sells cup and bag-type instant noodles and processed food products. The Chilled and Frozen Foods segment offers chilled and frozen food products. The Others segment includes confectioneries, beverages, food services, and businesses in Europe and Asia region. The company was founded by Momofuku Ando on September 4, 1948 and is headquartered in Tokyo, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sales of vitro diagnostic reagents and instruments for clinical immuno chemiluminescence diagnosis in China. Its products are LiCA series of diagnostic reagents based on photoexcitation chemiluminescence, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence. The company's products are used in the detection of infectious diseases such as hepatitis B, C, AIDS, syphilis, hepatitis A, and hepatitis E markers, tumor markers, thyroid hormones, reproductive endocrine hormones, and myocardial markers and inflammation. Chemclin Diagnostics was founded on May 10, 2007and is headquartered in Beijing, China.

Kunming Yunda Biotechnology Co., Ltd., established on 1999-01-19, Business scope includes research.to develop.Production.Sell ​​self-produced series of test strips for rapid detection,Reagent,Testing instruments and monoclonal antibodies and other products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

Zhongshan Bioengineering Co., Ltd., established on 1991-07-03, Business scope includes pharmaceutical production;Pharmaceutical business;second,Three types of medical device manufacturers;second,Three types of medical device operating enterprises;Production,Sales:Class I medical device;Import and export of goods and technology;Medical technology research and development;lease:First,two,Class III Medical Devices;Own house rental.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Scotgen Ltd. is a private company headquartered in Newcastle-under-Lyme, UK, also operating in GB, that develops renewable heat and power from waste and biomass.

Nanjing Shenji Pharmaceutical Technology Co., Ltd., established on 2018-08-02, Business scope includes medical technology research and development,technical consulting,Technical Services,technology transfer;Biotechnology R&D,technical consulting,Technical Services,technology transfer;experiment apparatus,Medical device research and development,Production,Sales;laboratory consumables,Chemical Products(Does not contain hazardous chemicals),Instrumentation,Electronic equipment,Machinery sales;Self-operated and agent import and export business of various commodities(Except for commodities and technologies that are restricted or prohibited by the state for import and export);Nutrition and Health Consulting Services;health service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Veterinary drug business;Veterinary drug production;Animal Clinic(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA.

BioChem ImmunoSystems, Inc. is a Canadian private company involved in pharmaceutical preparations.

Adaltis, Inc. is an international in-vitro diagnostic company. The company develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases and measure human hormone responses. Adaltis was founded on June 12, 1987 and is headquartered in Montreal, Canada.

Hebei Donghan Medical Equipment Technology Co., Ltd., established on 2012-12-13, Business scope includes research and development of medical devices,Technology Promotion;office equipment,Stationery,Daily necessities,Chemical Products(Except for hazardous chemicals and those requiring special approval),Computer hardware and software and peripheral auxiliary equipment,laboratory consumables,medical instruments(The operating permit)promotion of;Repair of Medical Devices(The operating permit),Conference and exhibition service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company was founded on June 12, 2000 and is headquartered in Anyang, South Korea.

Hangzhou LONGi Biotechnology Co., Ltd., established on 2004-06-09, Business scope includes technology development,technical consulting,Technical Services,Achievement transfer:Biotechnology,Biological product;Production:Food Safety Rapid Testing Products,medical instruments6840Clinical laboratory analysis instruments and in vitro diagnostic reagents;Sales:Biological raw materials for non-medical use,experimental reagent(Removal of hazardous chemicals and precursor chemicals),Experimental consumables,second,Class III Medical Devices,Experimental equipment,Primary Edible Agricultural Products(except food,medicine);Import and export(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)